review Open AccessTop 1% cited
Regulation and Function of the PD-L1 Checkpoint
Immunity · 2018 · Vol. 48(3) · pp. 434–452
Chong Sun(Oncode Institute)Riccardo Mezzadra(Oncode Institute)Ton N. Schumacher✉(The Netherlands Cancer Institute)
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune cells in cancerBiologyFunction (biology)Cancer researchCell biologyComputational biology
MeSH terms
AnimalsGene Expression RegulationHumansImmunotherapyLymphocyte ActivationNeoplasmsT-LymphocytesSignal TransductionMolecular Targeted TherapyB7-H1 AntigenProgrammed Cell Death 1 Receptor
Citations
2,208
FWCI
72.41
field-weighted impact
References
240
Percentile
100%
vs. same field & year
Citations per year
References
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
The EMBO Journal · 1992 · 3,162 citations
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
Nature Medicine · 1999 · 2,463 citations
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
The Lancet Oncology · 2015 · 1,554 citations
Molecular and cellular insights into T cell exhaustion
Nature reviews. Immunology · 2015 · 4,348 citations
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
New England Journal of Medicine · 2015 · 9,308 citations
AP-1 as a regulator of cell life and death
Nature Cell Biology · 2002 · 2,929 citations
Exploiting tumour hypoxia in cancer treatment
Nature reviews. Cancer · 2004 · 2,771 citations
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Journal of Clinical Oncology · 2010 · 2,913 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.